Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: The Genesis France-Belgium study

Diabetes Care

Volumn 27, Issue 11, 2004, Pages 2661-2668

  Hadjadj, Samy ^a,b   Péan, Franck ^b   Gallois, Yves ^c   Passa, Philippe ^d   Aubert, Robert ^b   Weekers, Laurent ^e   Rigalleau, Vincent ^f   Bauduceau, Bernard ^g   Bekherraz, Amine ^h   Roussel, Ronan ^b,h   Dussol, Bernard ⁱ   Rodier, Michel ^j   Marechaud, Richard ^a   Lefebvre, Pierre J ^e   Marre, Michel ^b,h  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Universite d'Angers   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f Groupe Hospitalier Sud CHU de Bordeaux   (France)

^g SERVICE D ENDOCRINOLOGIE   (France)

^h BICHAT HOSPITAL   (France)

ⁱ HÔPITAL SAINTE MARGUERITE   (France)

^j NÎMES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BELGIUM; CREATININE BLOOD LEVEL; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DYSLIPIDEMIA; FAMILY STUDY; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEINURIA; RELATIVE; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; ALBUMINURIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; SEVERITY OF ILLNESS INDEX;

EID: 7444223412     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.11.2661     Document Type: Article

References (53)

1. Klein R, Klein BE, Jensen SC, Moss SE: The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophthalmology 101:68-76, 1994
2. Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H: Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 313:779-784, 1996
3. Borch-Johnsen K, Kreimer S: Proteinuria: value as predictor of cardio-vascular mortality in insulin-dependent diabetes. BMJ 294:1651-1654, 1987
4. Borch-Johnsen K, Norgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH: Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722, 1992
5. Rogus JL, Krolewski AJ: Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk. Am J Hum Genet 59:1376-1381, 1996
6. Tarnow L, Rossing P, Nielsen FS, Fagerudd JA, Poirier O, Parving HH: Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 23:30-33, 2000
7. Earle K, Walker J, Hill C, Viberti G: Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326:673-677, 1992
8. Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS: Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 41:723-730, 1992
9. Freire MB, Ferreira SR, Vivolo MA, Oliveira JM, Zanella MT: Familial hypertension and albuminuria in normotensive type I diabetic patients. Hypertension 23:1256-1258, 1994
10. Fagerudd JA, Tarnow L, Jacobsen P, Stenman S, Nielsen FS, Pettersson-Fernholm KJ, Gronhagen-Riska C, Parving H-H, Groop P-H: Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 47:439-444, 1998
11. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165, 1989
12. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-depndent) diabetes mellitus. Diabetologia 33:438-443, 1990
13. Rema M, Saravanan G, Deepa R, Mohan V: Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med 19:910-916, 2002
14. The Diabetes Control and Complications Trial Research Group: Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829-1839, 1997
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 285:2486-2497, 2001
16. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
17. Mathiesen ER, Ronn B, Jensen T, Storm B, Decken T: The relationship between blood pressure and urinary albumin excretion in the development of microalbuminuria. Diabetes 39:245-249, 1990
18. Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL: Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int 64:817-828, 2003
19. Fagerudd JA, Pettersson-Fernholm KJ, Gronhagen-Riska C, Groop PH: The impact of a family history of type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with type I (insulin-dependent) diabetes mellitus. Diabetologia 42:519-526, 1999
20. Zhang L, Krzentowski G, Albert A, Lefebvre PJ: Factors predictive of nephropathy in DCCT type 1 diabetic patients with good or poor metabolic control. Diabet Med 20:580-585, 2003
21. Zhang L, Krzentowski G, Albert A, Lefebvre PJ: Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24:1275-1279, 2001
22. Chaturvedi N: Differing aspects of insulin resistance in diabetes complications: the shape of things to come: RD Lawrence Lecture 2000. Diabet Med 19:973-977, 2002
23. The Expert Comittee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Comittee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
24. Chaturvedi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songini M, Kohner EM: Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 24:284-289, 2001
25. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE: Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 62:963-970, 2002
26. Yip J, Mattock M, Sehti M, Morocutti A, Viberti G: Insulin resistance in family members of insulin-dependent diabetic patients with micoalbuminuria. Lancet 341:369-370, 1993
27. Verhage B, Vervoort G, Wolkotte C, Elving LD, Wetzels JF, Willems H, Smits P, Verbeek AL, Berden JH: Prevalence of "syndrome X" features in parents of type 1 diabetic patients with or without nephropathy. Diabetes Care 22:1048-1052, 1999
28. De Cosmo S, Bacci S, Piras GP, Cignarelli M, Placentino G, Margaglione M, Colaizzo D, Di Minno G, Giorgino R, Liuzzi A, Viberti GC: High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. Diabetologia 40:1191-1196, 1997
29. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99:1585-1595, 1997
30. Kohner EM: The lesions and natural history of diabetic retinopathy. In Textbook of Diabetes. Pickup J, Williams G, Eds. Oxford, U.K. Blackwell Scientific, 1991, p. 575-588
31. Bauduceau B, Chatellier G, Cordonnier D, Marre M, Mimran A, Monnier L, Sauvanet J-P, Valensi P, Balarac N: Arterial hypertension and diabetes: members of the Board of Directors and Scientific Directors of ALFEDIAM. Diabetes Metab 22:64-76, 1996
32. Marre M, Claudel JP, Ciret P, Luis N, Suarez L, Passa P: Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem 33:209-213, 1987
33. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
34. Armitage P, Berry G: Components of χ2. In Statistical Methods in Medical Research. Blackwell Scientific, Oxford, U.K., 1990, p. 469-472
35. Osei K, Rhinesmith S, Gaillard T, Schuster D: Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in non-diabetic, first-degree relatives of African-American patients with type 2 diabetes? J Clin Endocrinol Metab 88:4596-4601, 2003
36. Forsblom CM, Eriksson JG, Ekstrand AV, Teppo AM, Taskinen MR, Groop LC: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 38:363-369, 1995
37. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH: Prevalence in complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124, 1990
38. The EURODIAB IDDM Complications Study Group: Microvascular and acute complications in IDDM subjects: the EURODIAB IDDM Complications Study. Diabetologia 37:278-285, 1994
39. Asmar R, Pannier B, Vol S, Brisac AM, Tichet J, el Hasnaoui A: Cardiovascular risk factors in France: prevalence and association. Arch Mal Coeur Vaiss 95:239-245, 2002
40. Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, Tichet J, Eschwege E: The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: the French D.E.S.I.R. study. Diabetes Metab 29:526-532, 2003
41. Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E: Peroxisome proliferator-activated receptor-γ2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: the Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 51:2653-2657, 2002
42. Canani LH, Ng DP, Smiles A, Rogus JJ, Warram JH, Krolewski AS: Polymorphism in ecto-nucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1/PC-1) and early development of advanced diabetic nephropathy in type 1 diabetes. Diabetes 51:1188-1193, 2002
43. Norgaard K, Mathiesen ER, Hommel E, Jensen JS, Parving HH: Lack of familial predisposition to cardiovascular disease in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 34:370-372, 1991
44. Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Chevalier A, Slama G, Reach G, Selam JL: eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Mid 19:240-245, 2002
45. Lindsay RS, Little J, Jaap AJ, Padfield PL, Walker JD, Hardy KJ: Diabetic nephropathy is associated with an increased familial risk of stroke. Diabetes Care 22:422-425, 1999
46. Jones SF, Close CF, Mattock MB, Jarret RJ, Keen H, Viberti G: Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ 298:487-490, 1989
47. Hadjadj S, Gallois Y, Simard G, Bouhanick B, Passa P, Grimaldi A, Drouin P, Tichet J, Marre M: Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein: Genetique de la Nephropathie Diabetique Study Group: Donnees Epidemiologiques sur le Syndrome D'Insulino-Resistance Study Group. Nephrol Dial Transplant 15:1971-1976, 2000
48. Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH: Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 60:219-227, 2001
49. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285-2293, 2003
50. Hadjadj S, Duly-Bouhanick B, Bekherraz A, Brldoux F, Gallois Y, Mauco G, Ebran J, Marre M: Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 30:43-51, 2004
51. Chowdhury TA, Dyer PH, Kumar S, Gibson SP, Rowe BR, Davies SJ, Marshall SM, Morris PJ, Gill GV, Feeney S, Maxwell P, Savage D, Boulton AJM, Todd JA, Dunger D, Barnett AH, Bain SC: Association of Apolipoprotein E2 allele with diabetic nephropathy in Caucasian subjects with IDDM. Diabetes 47:278-280, 1998
52. Onuma T, Laffel LMB, Angelico MC, Krolewski AS: Apolipoprotein E genotypes and risk of diabetic nephropathy. J Am Soc Nephrol 7:1075-1078, 1996
53. Fumeron F, Aubert R, Siddiq A, Betoulle D, Pean F, Hadjadj S, Tichet J, Wilpart E, Chesnier MC, Balkau B, Froguel P, Marre M: Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the Epidemiologic Data on the Insulin Resistance Syndrome prospective study. Diabetes 53:1150-1157, 2004